Fermeate, a California-based startup, has raised $2 million in seed funding to enhance biomanufacturing through optogenetics, allowing precise control of gene expression with light to significantly boost protein production in fermentation processes. Their technology can integrate with existing fermentation systems, improving productivity without the need for costly new infrastructure.
Fermeate's use of optogenetics to control gene expression with light offers a transformative approach for businesses in the fermentation industry to significantly boost productivity without expanding physical capacity. Their technology can enhance protein production by 60-300%, offering a cost-effective solution to improve margins and efficiency by converting existing stainless-steel fermenters at a fraction of the cost of new installations. For someone tracking foodtech and alternative protein innovations, investing in or partnering with Fermeate could provide strategic leverage in optimizing production capabilities within existing infrastructures.